KUALA LUMPUR: Amidst pressure against Malaysia for using compulsory licensing (CL) to gain access to generic versions of a Hepatitis C drug, the Health Ministry has urged the World Health Organisation (WHO) to look into the pricing system of medicine by big pharmaceutical companies.
Deputy Health Minister Dr Lee Boon Chye (pic) said while Malaysia could exercise the rights provided for under the World Trade Organisation’s agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), the scope is limited to government use only.
